Evidence map›Paper›PMID 34685992›Full record

ArticlePlants (Basel, Switzerland)2021

Promising Natural Compounds against Flavivirus Proteases: Citrus Flavonoids Hesperetin and Hesperidin.

Raphael J Eberle, Danilo S Olivier, Marcos S Amaral, Dieter Willbold, Raghuvir K Arni, Monika A Coronado

Open access · goldAbstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Raphael J EberleInstitute of Biological Information Processing (IBI-7: Structural Biochemistry), Forschungszentrum Jülich, 52428 Jülich, Germany.ORCID 0000-0002-8763-3884
Danilo S OlivierIntegrated Sciences Center, Federal University of Tocantins, Araguaína 77824-838, Brazil.ORCID 0000-0003-1269-3783
Marcos S AmaralInstitute of Physics, Federal University of Mato Grosso do Sul, Campo Grande 79070-900, Brazil.ORCID 0000-0001-8101-6933
Dieter WillboldInstitute of Biological Information Processing (IBI-7: Structural Biochemistry), Forschungszentrum Jülich, 52428 Jülich, Germany.ORCID 0000-0002-0065-7366
Raghuvir K ArniMultiuser Center for Biomolecular Innovation, Departament of Physics, Universidade Estadual Paulista (UNESP), São Jose do Rio Preto 15054-000, Brazil.ORCID 0000-0003-2460-1145
Monika A CoronadoInstitute of Biological Information Processing (IBI-7: Structural Biochemistry), Forschungszentrum Jülich, 52428 Jülich, Germany.ORCID 0000-0002-6518-6497
Forschungszentrum Jülich · DEUniversidade Estadual Paulista (Unesp) · BRUniversidade Federal de Mato Grosso do Sul · BRUniversidade Federal do Tocantins · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ubiquitous in citrus plants, Hesperidin and Hesperetin flavanones possess several biological functions, including antiviral activity. Arbovirus infections pose an ever-increasing threat to global healthcare systems. Among the severe arboviral infections currently known are those caused by members of the Flavivirus genus, for example, Dengue Virus-DENV, Yellow Fever Virus-YFV, and West Nile Virus-WNV. In this study, we characterize the inhibitory effect of Hesperidin and Hesperetin against DENV2, YFV, and WNV NS2B/NS3 proteases. We report the noncompetitive inhibition of the NS2B/NS3

Indexed as

flavivirushesperetinhesperidinnoncompetitive inhibitorsNS2B/NS3pro

Identifiers

PMID34685992
PMCPMC8539695
OpenAlexW3205168864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.